Oncology

Ziopharm Oncology presents preclinical data for Darinaparsin at AACR-NCI-EORTC meeting

Ziopharm Oncology announced that results from preclinical studies of darinaparsin (Zinapar or ZIO-101), a novel organic arsenic, in prostate cancer were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. In addition to company authors, the studies included authors Joseph R Bertino MD and Nitu Bansal PhD from UMDNJ-The Cancer Institute of New Jersey.

Oncology | 23 November 2011

• Ziopharm Oncology
• preclinical data
• Darinaparsin
• Hedgehog Signaling Pathway
• Prostate Cancer

BeiGene in-licenses two clinical-stage oncology compounds

BeiGene will collaborate with Janssen in phase III clinical trials in melanoma and explore additional solid tumor indications in solid tumors prevalent in China and Asia.

Oncology | 15 October 2011

• Janssen

GE Healthcare to invest US$1 billion in new oncology solutions

Expanding advanced cancer diagnostic and molecular imaging capabilities.

Oncology | 19 September 2011

• GE Healthcare

BMS, Innate Pharma announce agreement on immuno-oncology biologic

Bristol-Myers Squibb Company and Innate Pharma SA announced a global agreement for the development and commercialization of IPH2102, a novel antibody in phase 1 development for the treatment of cancer. Under the terms of the agreement, Innate Pha…

Oncology | 07 July 2011

AstraZeneca, PTC Therapeutics announce strategic oncology drug discovery collaboration

AstraZeneca and PTC Therapeutics Inc announced that they have entered into an exclusive research collaboration and license agreement. This is for the application of PTC’s proprietary GEMS technology (Gene Expression Modulation by Small-molecules) f…

Oncology | 30 June 2011

INC Research expands oncology executive team

INC Research LLC announced that Chris Smyth, PhD, MBA, has joined its oncology leadership team as Senior Vice President, Clinical Development. Based out of INC Research’s European headquarters in Winnersh, UK, Dr. Smyth will leverage his extensive …

Oncology | 28 June 2011

Roche and Evotec to jointly develop biomarkers in oncology

An alliance for personalized healthcare in cancer research and development.

Oncology | 24 June 2011

PRECOS and Argenta extend collaboration in oncology drug discovery services

Preclinical Oncology Services Limited (PRECOS) has extended its alliance with Argenta to continue providing comprehensive oncology-focussed drug discovery services. Argenta, a service division of Galapagos NV, provides fully integrated drug discove…

Oncology | 23 March 2011